Skip to main content
. 2024 Nov 1;26(11):euae273. doi: 10.1093/europace/euae273

Figure 2.

Figure 2

Cumulative incidence functions of all-cause mortality at 2 years in Micra AV vs. dual-chamber transvenous patients. Unadjusted (A) and adjusted (B) HRs, 95% CIs, and cumulative incidence functions for 2-year all-cause mortality based on Fine–Gray competing risk models. CI, confidence interval; DC, dual-chamber; HR, hazard ratio.